Amgen Prepares for Q3 Earnings Report: Key Expectations
Oct 23, 2024
Amgen Investment Portfolios
Amgen Prepares for Teprotumumab Application Submission to EMA
Apr 27, 2024
Amgen Inaugurates Cutting-Edge Biomanufacturing Plant in Central Ohio
Feb 27, 2024
Xeris Pharmaceuticals (XERS) Rises on Strategic Licensing Agreement With Amgen for Tepezza Development
Jan 12, 2024
A Comprehensive Look at the Most Promising Dow Stocks for 2024
Dec 30, 2023